Amphastar Pharmaceuticals...

NASDAQ: AMPH · Real-Time Price · USD
30.48
0.27 (0.89%)
At close: Aug 15, 2025, 12:11 PM

Amphastar Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
712.81M 644.39M 498.99M 437.77M
Cost of Revenue
338.96M 293.27M 250.13M 238.03M
Gross Profit
373.86M 351.12M 248.86M 199.74M
Operating Income
205.42M 196.99M 107.5M 69.89M
Interest Income
10.61M 5.46M 1.32M 601K
Pretax Income
189.76M 169.38M 114.86M 84.14M
Net Income
159.52M 137.54M 91.39M 62.12M
Selling & General & Admin
94.52M 80.39M 66.59M 68.92M
Research & Development
73.91M 73.74M 74.77M 60.93M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
168.44M 154.13M 141.36M 129.85M
Interest Expense
30.34M 27.16M 1.85M 885K
Selling & Marketing Expenses
37.8M 28.85M 21.53M 17.49M
Cost & Expenses
507.39M 447.41M 391.49M 367.88M
Income Tax Expense
29.67M 31.83M 23.48M 20.63M
Shares Outstanding (Basic)
48.43M 48.27M 48.55M 47.78M
Shares Outstanding (Diluted)
52.06M 53M 52.43M 49.78M
EPS (Basic)
3.29 2.85 1.88 1.30
EPS (Diluted)
3.06 2.60 1.74 1.25
EBITDA
277.31M 240.29M 146.16M 111.78M
EBIT
220.11M 198.52M 117.89M 85.02M
Depreciation & Amortization
57.2M 41.78M 28.27M 26.75M